02-12 Meeting Information

Meeting Information

TOPIC: Nanotechnology

SPEAKER: Richard C. Pleus, PhD - Managing Director, Intertox Inc.

Speaker Biography:

RICHARD C. PLEUS, Ph.D., is the managing director of Intertox Inc. He has over 25 years’ experience as a toxicologist assessing the risk to humans exposed to chemical and biological agents via water, air, soil, therapeutic agents, and consumer products.

Dr. Pleus’ current focus is on developing environmental health and safety (EHS) standards for nanomaterials and assisting in the evaluation of EHS risks from exposure to engineered nanoparticles through his participation as a U.S. delegate on the International Organization for Standardization (ISO) Technical Committee (TC) 229, Nanotechnologies. Dr. Pleus is also leading the U.S. Technical Advisory Group (TAG) Working Group 3 to develop a comprehensive list of physical and chemical characterization parameters of engineered nano-objects for toxicologic assessment.

Dr. Pleus is a U.S. delegate for the U.S.-Russia Bilateral Presidential Commission on Science and Technology. He was selected for his expertise on nano-related EHS issues. Dr. Pleus is the Chair of the Science Advisory Board of the Development and Launch of an Interoperable and Curated Nanomaterial Registry, a program funded by a number of federal agencies including NIH. He served on the NIOSH Nanotechnology Research Center review panel for intramural proposals, and he served as co-chair for the In Vitro Plenary of the National Nanotechnology Initiative Workshop titled "Nanomaterials and Human Health & Instrumentation, Metrology, and Analytical Methods." Dr. Pleus is co-founder of the Nanotechnology Health and Safety Forum.

Dr. Pleus is the founder and managing director of Intertox, Inc., an independent scientific consulting and research organization and co-founder and Chief Scientist of Intertox Decision Sciences, LLC, a risk management company offering software and database solutions for several industries including nanotechnology. Dr. Pleus is assisting with a number of product-related nanotechnology issues with companies around the world. His credentials include a B.S. in Physiology, with honors, from Michigan State University; an M.S. in Environmental Health and a Ph.D. in Environmental Toxicology from the University of Minnesota; and postdoctoral research in neuropharmacology at the University of Nebraska Medical Center.

WHO: Clinical, Data Management, Finance, Legal, Manufacturing, Medical, Operations, Pharmacovigilance, Quality, and Regulatory.

WHEN: Wednesday, February 15, 2012

Registration: 7:30 am - 8:00 a.m.

Meeting: 8:00 a.m. - 10:00 a.m

WHERE: Talaris Conference Center

4000 NE 41st Street

Seattle, WA 98105

FEES*: ORCA Members - No Charge

Non-members - $60.00

*(All credit card payments will be charged a $5 processing fee)

This meeting includes:

- Continental breakfast.

Attendance at this meeting may be applied as 1.5 points towards RAC re-certification